Assessment of Plateletcrit as Biomarker in Ischemic Heart Disease Patients

SHORT COMMUNICATION
Awad-Elkareem Abass

 
For citation: Abass AE. Assessment of Plateletcrit as Biomarker in Ischemic Heart Disease Patients. International Journal of Biomedicine. 2025;15(1):222-225. doi:10.21103/Article15(1)_ShC1
 
Originally published March 5, 2025

Abstract: 

Background: Platelets are crucial in initiating the formation of atherosclerosis and thrombus in ischemic heart disease. Larger platelets are enzymatic and metabolically active and have a higher potential thrombotic ability. Evaluation of their volume indices as indicators of their activity could be valuable in predicting and differentiating different ischemic heart disease (IHD) spectrums. This study aimed to assess plateletcrit (PCT) levels in IHD patients and compare them with healthy subjects.
Methods and Results: A cross-sectional, hospital-based study was conducted in different specialized cardiovascular centers in Khartoum state, Sudan. 95 IHD patients were categorized into two groups. Group 1 included 57 patients with ST-elevation myocardial infarction (STEMI), and Group 2 included 38 patients with chronic stable angina (CSA). The control group (Group 3) included 100 healthy subjects without a history of IHD, who were age—and sex-matched to the patient groups.
PCT was measured as part of the full blood count by an automated blood cell analyzer, Sysmex KX-21. Groups 1 and 2 had significantly higher PCT than the normal controls. PCT level was slightly higher in Group 1 than in Group 2. There were no age or gender differences in PCT values in the control group.
Conclusion: Plateletcrit should be investigated in patients with IHD, along with other platelet volume indices, to predict the possibility of developing acute coronary events.

Keywords: 
plateletcrit • ischemic heart disease • acute coronary syndrome
References: 
  1. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM. 2006 Jan;8(1):27-31. doi: 10.1017/s148180350001335x. PMID: 17175627.
  2. Mandal S, Saha JB, Mandal SC, Bhattacharya RN, Chakraborty M, Pal PP. Prevalence of ischemic heart disease among urban population of siliguri, west bengal. Indian J Community Med. 2009 Jan;34(1):19-23. doi: 10.4103/0970-0218.44518. PMID: 19876450; PMCID: PMC2763663.
  3. Bracey A, Meyers HP. Posterior Myocardial Ischemia (Archived). 2023 Apr 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30860754.
  4. Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease - what does it mean? Thromb Res. 2007;120(1):11-3. doi: 10.1016/j.thromres.2006.09.002. Epub 2006 Oct 12. PMID: 17046049.
  5. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. 2005 Apr 19;45(8):1157-64. doi: 10.1016/j.jacc.2005.01.034. PMID: 15837243.
  6. Boos CJ, Lip GY. Platelet activation and cardiovascular outcomes in acute coronary syndromes. J Thromb Haemost. 2006 Dec;4(12):2542-3. doi: 10.1111/j.1538-7836.2006.02250.x. Epub 2006 Oct 5. PMID: 17026647.
  7. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost. 2003 Jul;9(3):177-90. doi: 10.1177/107602960300900301. PMID: 14507105.
  8. Jesty J, Yin W, Perrotta P, Bluestein D. Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time. Platelets. 2003 May;14(3):143-9. doi: 10.1080/0953710031000092839. Erratum in: Platelets. 2003 Sep;14(6):399. PMID: 12850838.
  9. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990 May 31;322(22):1549-54. doi: 10.1056/NEJM199005313222201. PMID: 2336086.
  10. Mehta SR, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J. 2000 Dec;21(24):2033-41. doi: 10.1053/euhj.2000.2474. PMID: 11102254.
  11. Schoene NW. Design criteria: tests used to assess platelet function. Am J Clin Nutr. 1997 May;65(5 Suppl):1665S-1668S. doi: 10.1093/ajcn/65.5.1665S. PMID: 9129507.
  12. Ntolios P, Papanas N, Nena E, Boglou P, Koulelidis A, Tzouvelekis A, Xanthoudaki M, Tsigalou C, Froudarakis ME, Bouros D, Mikhailidis DP, Steiropoulos P. Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis. Clin Appl Thromb Hemost. 2016 May;22(4):346-50. doi: 10.1177/1076029615618023. Epub 2015 Dec 9. PMID: 26659450.
  13. Halbmayer WM, Haushofer A, Radek J, Schön R, Deutsch M, Fischer M. Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Coron Artery Dis. 1995 May;6(5):397-402. doi: 10.1097/00019501-199505000-00007. PMID: 7655727.
  14. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002 Apr 19;296(5567):539-41. doi: 10.1126/science.1068711. PMID: 11964481.
  15. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006 Dec 8;99(12):1293-304. doi: 10.1161/01.RES.0000251742.71301.16. PMID: 17158345.
  16. Dalby Kristensen S, Milner PC, Martin JF. Bleeding time and platelet volume in acute myocardial infarction--a 2 year follow-up study. Thromb Haemost. 1988 Jun 16;59(3):353-6. PMID: 3187927.
  17. Lewis SM, Bain BJ, Bates I. Dacie and Lewis Practical Haematology.  Philadelphia: Churchill Livingstone, 2006.
  18. Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol. 2006 Feb;59(2):146-9. doi: 10.1136/jcp.2004.025387. PMID: 16443728; PMCID: PMC1860313.
  19. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005 Jul 19;46(2):284-90. doi: 10.1016/j.jacc.2005.03.065. PMID: 16022956.
  20. Khode V, Sindhur J, Kanbur D, Ruikar K, Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res. 2012 Oct;3(4):272-5. doi: 10.4103/0975-3583.102694. PMID: 23233769; PMCID: PMC3516005.
  21. Abass AE, Yassir T, Saeed Y,  Taha A, Basheer A, Mubarak E, et al. Investigation of platelets count and indices in coronary artery diseases among Sudanese patients. IOSR J Dent and Med Scien.2016; 15(1):43-46. doi: 10.9790/0853-15184346
  22. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002 May;117(2):399-404. doi: 10.1046/j.1365-2141.2002.03441.x. PMID: 11972524.
  23. Sansanayudh N, Numthavaj P, Muntham D, Yamwong S, McEvoy M, Attia J, Sritara P, Thakkinstian A. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015 Nov 25;114(6):1299-309. doi: 10.1160/TH15-04-0280. Epub 2015 Aug 6. PMID: 26245769.
  24. Al-Obeidi SRH, Ahmedm SH, Obeid FA. Evaluation of Platelet Indices in Patients with Acute Coronary Syndrome. Mustansiriya Medical Journal. 2013;12.1. Available from: https://www.iasj.net/iasj/download/91b718c9821a63f1
  25. Assiri AS, Jamil AM, Mahfouz AA, Mahmoud ZS, Ghallab M. Diagnostic importance of platelet parameters in patients with acute coronary syndrome admitted to a tertiary care hospital in southwest region, Saudi Arabia. J Saudi Heart Assoc. 2012 Jan;24(1):17-21. doi: 10.1016/j.jsha.2011.08.004. Epub 2011 Oct 20. PMID: 23960663; PMCID: PMC3727553.
  26. Jasani J, Modi M, Vaishnani H, Gharia B, Shah Y,  Patel D, Patel R, Bhruguvanshi V, Vachhani D. Evaluation of platelet count and platelet indices in patients with coronary artery disease. IJBAR. 2014: 5(11): 553-555.

Download Article
Received November 11, 2024.
Accepted December 12, 2024.
©2025 International Medical Research and Development Corporation.